Vertex Pharmaceuticals
VRTX
VRTX
1,600 hedge funds and large institutions have $115B invested in Vertex Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 207 funds opening new positions, 635 increasing their positions, 571 reducing their positions, and 126 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
11% more repeat investments, than reductions
Existing positions increased: 635 | Existing positions reduced: 571
3% more funds holding
Funds holding: 1,547 → 1,600 (+53)
0.4% more ownership
Funds ownership: 91.72% → 92.12% (+0.4%)
Holders
1,600
Holding in Top 10
26
Calls
$771M
Puts
$596M
Top Buyers
| 1 | +$1.99B | |
| 2 | +$699M | |
| 3 | +$595M | |
| 4 |
Jennison Associates
New York
|
+$361M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$216M |
Top Sellers
| 1 | -$723M | |
| 2 | -$306M | |
| 3 | -$224M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$155M |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
-$152M |